• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
AVR

ANTERIS TECHNOLOGIES GLOBAL CORP. - News & Media

0.90% ! $5.60
Market Cap $86.68M  !
Healthcare Medical Devices
Add to My Watchlist

Anteris Technologies Global Corp. is a structural heart company, which is engaged in... Anteris Technologies Global Corp. is a structural heart company, which is engaged in providing cardiac care by science-driven and measurable advancements to restore heart valve patients to healthy function. Its lead asset, the DurAVR Transcatheter Heart Valve System (THV) consists of a single-piece, biomimetic valve made with its ADAPT tissue-enhancing technology and deployed with its ComASUR balloon-expandable delivery system. DurAVR THV is a novel transcatheter aortic valve for the treatment of aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. DurAVR THV’s single-piece design mimics the native anatomy of a human aortic valve, as compared to traditional three-piece aortic valves. The Company’s ADAPT is its proprietary anti-calcification tissue shaping technology that is designed to reengineer xenograft tissue into a pure, single-piece collagen bioscaffold. Its ComASUR delivery system is a physician-developed balloon expandable delivery system.More

Articles & Videos

Anteris Tech eyes US market liquidity with early-stage NASDAQ IPO paperwork

Anteris Technologies (ASX:AVR) revealed on Monday it's sent off early-stage paperwork to the US regulator for a proposed NASDAQ IPO.

25 Nov 2024 11:57 (AEDT)

Anteris the latest to flee a struggling ASX for Wall Street's NASDAQ

Anteris (ASX:AVR) has announced it intends to re-domicile and set up digs on the Wall Street NASDAQ index – joining Tamboran Energy, and until plans fell through, Telix.

13 Aug 2024 10:24 (AEST)

Anteris Technologies (ASX:AVR) secures utility patent for transcatheter heart valve

Anteris (ASX:AVR) has been issued a utility patent from the US Patent and Trademark Office for its novel DurAVR transcatheter heart valve.

12 Apr 2023 11:21 (AEST)

Anteris Technologies (ASX:AVR) launches $35m capital raise as FDA approves DurAVR study

Anteris Technologies (ASX:AVR) has launched a $35 million capital raise for the clinical development of its DurAVR transcatheter heart valve (THV) system.

09 Feb 2023 14:58 (AEDT)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
$5.60 		Change
0.050(0.90%) 		Mkt cap ! $86.68M
Open High Low Value Volume
$5.50 $5.69 $5.50 $43.31K 7.754K

Buyers (Bids)

No. Vol. Price($)
1 6954 $5.60
 

Sellers (Offers)

Price($) Vol. No.
$5.65 500 1
View Market Depth
Last trade - 15.01pm 11/08/2025 (20 minute delay) ?
AVR (ASX) Chart

Top Stories

Monday's HotCopper trends: DRO civ counterdrone, Dateline drill hits | Aug 11

DroneShield (ASX:DRO) has captured the most attention across the HotCopper forums through Week 33’s first trade day, sparking excitement with its new @SentryCiv,” a subscription-based AI counterdrone solution.Listen to the HotCopper podcast for in-depth discu...
Can the market squeeze IDP Education's shorters? As of Week 33, it looks possible IDP Education (ASX:IEL), a company that ultimately trains up foreign students moving to Australia, has long been one of the most...
DroneShield's civilian counter-drone tech lands with a buzz A silent guardian, standing tall and watching the skies. No, it’s not a superhero, but DroneShield’s (ASX:DRO) newest brainchild, SentryCiv: A new subscription-based counter-drone system for the civilian market.Listen to the HotCopper podcast for in-depth discussio...
The cash flow on demand strategy that works This week on Money and Investing, Mitch Olarenshaw and I break down the strategy behind Cash Flow on Demand @ a proven system for generating consistent income from the sharemarket with lower risk.1. The cash flow on demand strategyThis income strategy has been our flagship approach at Australian ...
Dateline's Colosseum project shaping as a 'buried treasure ready to shine' Dateline Resources (ASX:DTR) has surged as much as +10% in afternoon trade after digging into something exciting @ literally.Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.Their latest 3D mag...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.